Behind the Mystery: Diagnosing Endogenous Cushing Syndrome
July 20, 2016
Strongbridge Biopharma: Driven by Passion. Focused on Results.
On today’s special series “Behind the Mystery,” we’re talking about Cushing syndrome, a rare hormonal disorder that is too often misdiagnosed where patients are simply told to lose weight! An estimated 25,000 patients in the United States and 40,000 patients in Europe are currently diagnosed with endogenous Cushing syndrome. Endogenous Cushing syndrome is believed to be underdiagnosed due to lack of disease recognition by the treating physician, which often leads to a delay in diagnosis on average of six years. Host Olga Villaverde will talk with Dr. Maria Fleseriu and patient Leslie Edwin, to raise awareness about Cushing syndrome and discuss symptoms and ways to properly diagnosis it.
Dermarest Psoriasis with salicylic acid and a unique zinc complex is specially formulated to truly treat psoriasis and relieve symptoms. Plus, Dermarest medical lotion provides immediate itch relief due to eczema.
The importance of an open dialogue with a HER2+ breast cancer diagnosis, plus how to be informed and proactive in your treatment decisions.
Sea Cuisine is a family of delicious chef-crafted glazed, crusted, or hand-seasoned frozen seafood products that bring the taste and inspiration of the sea to your table.